341 results about "Function proteins" patented technology

The present invention relates to various molecular constructs having at least one cellular-targeting element, one protein-targeting element, and one ubiquitin ligase recruitment element, wherein these elements are conjugated in a manner that facilitates cellular uptake and targeted degradation of specific proteins within cells. The present invention further relates to multifunctional proteolysis-targeting chimera conjugates and uses thereof for the treatment of diseases or disorders such as immune and inflammatory diseases, infectious diseases, cardiovascular diseases, endocrine disorders, and various cancers that are otherwise resistant to traditional therapeutic regimens.

The invention provides a protein methylation site prediction method fusing quantum and region perception, which comprises the following steps: step 1, acquiring a protein sequence as a data source, and respectively constructing a training set and an independent test set; 2, constructing a multi-modal feature for each protein sequence by adopting a three-way nested scattering network, and fusing the multi-modal features to obtain an optimized fusion feature tensor; and step 3, inputting the optimized fusion feature tensor into a RaQMeNet network model, and performing a methylation site prediction task. The performance indexes of the method are greatly superior to those of the prior art, and the method has higher adaptability, stability and interpretability, can be widely applied to a plurality of bioinformatics and biological medicine related fields such as protein function annotation, disease mechanism research and drug target discovery, and has good application prospects and commercial values.

A method of predicting protein functions and interactions, including identifying a first protein and a second protein for analysis, generating a first embedded representation of a first amino acid sequence of the first protein and a second embedded representation of a second amino acid sequence of the second protein, generating a first contact map prediction for the first protein based on the first amino acid sequence and a second contact map prediction for the second protein based on the second amino acid sequence, generating first physiochemical features associated with the first protein, and second physiochemical features associated with the second protein, and generating a prediction score for a protein function or interaction between the first protein and the second protein based on the first embedded representation, the second embedded representation, the first contact map prediction, the second contact map prediction, the first physiochemical features and the second physiochemical features.

The invention provides a design method of a protein variant structure based on molecular dynamics, and belongs to the technical field of molecular dynamics simulation. A protein-standard nucleic acid compound ground molecule system and a protein-nonstandard sequence compound ground molecule system are respectively constructed, and based on a molecular dynamics simulation technology, protein conformation stability, low-energy conformation states, main change processes, collaborative movement and key residues of the protein-standard sequence system and the protein-nonstandard sequence system are compared, so that protein conformation stability and low-energy conformation states of the protein-standard nucleic acid compound ground molecule system and the protein-nonstandard sequence compound ground molecule system are obtained. The molecular mechanism of protein-nucleic acid interaction is analyzed, the recognition behavior of the protein on the standard nucleic acid sequence and the activation process of the standard nucleic acid sequence on the corresponding function of the protein are understood from the molecular level, and finally the protein variant with more related functions is designed.

The invention discloses a therapeutic nano-vesicle preparation rich in mitochondrial functional protein, a preparation method of the therapeutic nano-vesicle preparation and application of the therapeutic nano-vesicle preparation in treatment of radioactive skin injury. The preparation method comprises the following steps: culturing, amplifying and cleaning umbilical cord mesenchymal stem cells, dispersing the umbilical cord mesenchymal stem cells in a suspension, mechanically extruding the umbilical cord mesenchymal stem cells into a crude solution through a multistage aperture polycarbonate membrane, and centrifuging, concentrating and purifying the crude solution to obtain the preparation. The preparation has the remarkable advantages that local administration can be realized, inflammation can be quickly inhibited, oxidative stress is reduced, and a repair pathway is activated, so that the preparation is suitable for treating acute radioactive skin injury; the preparation method is easy to standardize and scale, high in stability and convenient for emergency storage and delivery, and avoids the defects of cell therapy; a plurality of targets such as immune inflammation, oxidative stress and the like can be synergistically regulated, the biological effect of hUMSCs is simulated and partially replaced, and the limitation caused by the cell survival rate and the microenvironment dependency is avoided; the key function of hUMSCs is covered in function, and the clinical feasibility, safety and emergency suitability of the application level are higher.

The invention provides application of ancient-Chinese health-preserving essence in preparation of a protein regulating agent, and belongs to the technical field of biological medicines. The invention provides application of an ancient-Chinese health-preserving essence or an ancient-Chinese health-preserving essence extract in preparation of a reagent for regulating protein functions. Protein comprises at least one of NCAM2, NCAM1, MAP2, VGLUT1, CDK5, DCLK1, TUBB3 and apolipoprotein E. The invention also provides an application of the ancient-Chinese health-preserving essence or the ancient-Chinese health-preserving essence extract in preparation of a reagent for regulating protein functions. In ancient and Chinese health preserving essence positive feedback regulation proteins, an important nerve synaptic function network exists and comprises proteins such as NCAM2, NCAM1, MAP2 and the like, and the proteins play an important role in biological processes such as neural development, synaptic shaping, neural signal transmission and the like. In addition, the ancient-Chinese health-preserving essence can regulate the expression of APOE. The application of the invention not only helps to deepen the scientific understanding of the pharmacodynamic effect of the ancient-Chinese health-preserving essence, but also provides a theoretical basis for the modern and precise application of traditional Chinese medicine compounds.

The invention provides a fusion protein for promoting proliferation of hair follicle stem cells as well as a preparation method and application of the fusion protein. The fusion protein is formed by fusion expression of a plurality of collagen structural domains capable of being combined with cell integrin and / or specific structural domains from certain functional proteins screened from collagen XVII and III type collagen. Nucleic acid molecules for coding the fusion protein are subjected to codon optimization and then recombined and stably expressed in escherichia coli to obtain the fusion protein. The fusion protein has excellent performance of promoting proliferation and migration of human hair follicle stem cells and human fibroblasts, can be used for repairing skin and hair follicle tissues and improving resistance of skin and hair follicles, and is suitable for popularization and application in the fields of beauty and skin care, medical equipment, tissue engineering and the like.

The invention relates to a gene GL8 for controlling grain shape, appearance quality or / and yield of rice. The gene has (a) a nucleotide sequence as shown in SEQ ID No: 1; and (b) a nucleotide sequence which is generated by adding, substituting or deleting one or more basic groups from the nucleotide sequence as shown in SEQ ID No: 1 and is used for coding a functional protein for controlling the grain shape, the appearance quality and the yield of rice. The invention belongs to the technical field of gene engineering. By overexpressing the gene, the grain shape, appearance quality and yield of rice can be regulated and controlled.

The invention provides a multifunctional protein MZM29 and application thereof, and belongs to the technical field of biological medicine. The multifunctional protein MZM29 or the homologous multifunctional protein of the MZM29 provided by the invention comprises an amino acid sequence as shown in any one of SEQ ID NO.1-12; or a partial segment comprising any one or more of the amino acid sequences shown as SEQ ID NO.1-12, or a partial segment comprising any one or more of the amino acid sequences shown as SEQ ID NO.1-12; or a sequence having more than 80% of homology with any one amino acid sequence of SEQ ID NO.1-12. The multifunctional protein MZM29 has relatively good antibacterial and anti-inflammatory effects, and shows antiviral activity to HPV16 and HPV18. Good application prospects are shown in preparation of antibacterial, anti-inflammatory or anti-virus products.

The invention discloses a recombinant protein and application thereof in preparation of sodium alginate fibers. The recombinant protein is obtained by fusion expression of a functional protein and at least one alginic acid binding domain protein. The amino acid sequence of the alginic acid binding domain protein is as shown in at least one of SEQ ID No. 1, SEQ ID No. 2 and SEQ ID No. 3. The recombinant spider silk protein with the alginic acid CBM region can exert the material science characteristics in a sodium alginate-calcium ion system, the mechanical property of alginic acid fiber is greatly enhanced, and meanwhile, the biological activity of protein can be provided for an alginate fiber system.

The invention discloses a protein function prediction method based on multi-modal fusion and a dynamic label network, and belongs to the technical field of biological information, an adjacent matrix of a label association network can be smoothly updated in a model training process, and the protein function prediction method can be used for predicting protein functions by extracting various modal information of protein. The redundant relation among multiple modes is removed, the prediction effect of protein functions is improved, meanwhile, a training method combining a protein function association network and a tag association network is used, the influence of multiple tags on protein function prediction is considered, and protein function prediction is achieved by fusing the sequence, structure and structural domain information of protein. According to the method, the complementarity of various data is fully utilized, so that the prediction capability of the model is improved, and compared with a traditional method using a static label relationship, the scheme dynamically updates the label relationship in model training, so that the generalization capability of the model is further improved.

The invention relates to the technical field of artificial intelligence, and provides a protein function prediction method and device based on multi-modal protein data, and the method comprises the steps: obtaining protein multi-source data, carrying out the feature extraction of a protein sequence in the protein multi-source data, and obtaining a protein sequence feature; constructing a heterogeneous graph based on the protein multi-source data; performing feature coding on the heterogeneous graph by adopting a graph attention mechanism to obtain protein graph features; performing multi-modal fusion on the protein sequence features and the protein map features by adopting a gating fusion mechanism to obtain fusion features; and performing multi-label classification prediction based on the fusion features to obtain a protein function annotation result. The accuracy and robustness of protein function prediction can be improved, and the problems that in the prior art, multi-source protein data cannot be effectively integrated, and the method is sensitive to data noise are solved.

The invention provides application of an FAP protein function inhibitor in preparation of a medicine for inhibiting formation of fibrous scars. The invention finds that the formation of the fibrous scar can be obviously inhibited by knocking out the Fap gene and inhibiting the activity of the FAP protein, so that the FAP protein function inhibitor can be used for preparing the medicine for inhibiting the formation of the fibrous scar. Besides, the invention also finds that the expression levels of the Fap gene and the FAP protein are also increased along with the development of the fibroscar disease course, which indicates that the FAP can be used as a marker of the fibroscar, that is, the FAP can be used as a target for screening products for inhibiting the formation of the fibroscar, and a detection reagent of the FAP can be used for preparing fibroscar diagnosis products and / or prognosis evaluation products.

The invention relates to the technical field of protein purification, in particular to a purification method of label-free A53T mutant alpha-synuclein. The purification method disclosed by the invention is a purification method which is more efficient and economical and can maintain protein functions, 20mg of protein can be obtained by inducing 1L of bacterial liquid for 4 hours through IPTG, and the method can improve the overall effect and experimental accuracy of preparation of the label-free A53T alpha mutant-synuclein monomer.

The invention provides a VvYUC10 gene, the nucleotide sequence of the VvYUC10 gene is as shown in SEQ ID No.1, or the nucleotide sequence which is obtained by substituting, deleting and / or adding one or more nucleotides to the nucleotide sequence as shown in SEQ ID No.1 and expresses proteins with the same function; the invention also provides an application thereof. The grape VvYUC10 gene has the advantages that the function of the grape VvYUC10 gene is verified, it is found that the content of auxin in calluses of overexpressed VvYUC10 arabidopsis thaliana and grapes under salt stress is increased, the oxidation resistance is enhanced, and it is further found that the expression quantities of the VvRD22 gene, the VvDREB2A gene, the VvRD29A gene, the VvP5CS gene, the VvCAT1 gene and the VvSOD gene are increased; finally, it shows that the VvYUC10 gene positively regulates and controls the auxin signal channel to positively resist external adverse environmental factor salinization, and a theoretical reference basis is provided for grape salt-tolerant gene mining and breeding.

The invention discloses a scorpion-derived polypeptide and application thereof, and belongs to the technical field of functional proteins. The amino acid sequence of the polypeptide derived from the Buthus martensii Karsch is as shown in SEQ ID NO. 1, SEQ ID NO. 2, SEQ ID NO. 3, SEQ ID NO. 4 or SEQ ID NO. 5. The polypeptide derived from the Buthus martensii Karsch is a polypeptide derived from the Buthus martensii Karsch. The invention also provides an application of the buthus martensii-sourced polypeptide with the amino acid sequence shown as SEQ ID NO. 1 in preparation of a blood coagulation promoting drug and an application of the buthus martensii-sourced polypeptide with the amino acid sequence shown as SEQ ID NO. 2, SEQ ID NO. 3, SEQ ID NO. 4 or SEQ ID NO. 5 in preparation of a blood coagulation promoting drug. The buthus martensii-sourced polypeptide provided by the invention has a relatively good application value in the aspect of research and development of antithrombotic drugs or coagulant drugs.

Provided are a GLP-1GIP analog, an FGF21 protein, a trifunctional protein, and use thereof. The trifunctional protein comprises the GLP-1 / GIP analog and the FGF21 protein. Further provided is use of the GLP-1 / GIP analog, the FGF21 protein, and the trifunctional protein in the preparation of a drug for preventing and / or treating diseases related to GLP-1, GIP, and / or FGF21. The provided GLP-1 / GIP analog, FGF21 protein, and trifunctional protein can synergistically regulate blood glucose and lipid levels in vivo, meet multiple needs in patients with type 2 diabetes, including lowering blood glucose, alleviating hepatic steatosis, promoting weight loss, ameliorating circulating lipid metabolism disorder, etc., and have better biological safety and tolerability and longer in vivo half-lives.

Provided herein is disclosure of a recombinant bifunctional protein or polypeptide capable of binding to a cell surface receptor for lysosome targeting that is made up of an N-glycosylated peptide comprising at least one N-glycan group and a protein of interest, or antibody or antibody fragment capable of binding to a protein of interest. Also provided herein are methods for producing said recombinant bifunctional protein. Also provided herein are methods for lysosomal degradation of a protein of interest comprising introducing to a cell the peptide sequence of the recombinant bifunctional protein.

The invention discloses a GLP-1 GIP analogue, an FGF21 protein, a three-function protein and an application thereof. The trifunctional protein comprises a GLP-1 / GIP analogue and an FGF21 (Fibroblast Growth Factor 21) protein. The invention also discloses application of the GLP-1 / GIP analogue, the FGF21 protein and the three-function protein in preparation of medicines for preventing and / or treating diseases related to GLP-1, GIP and / or FGF21. The GLP-1 / GIP analogue, the FGF21 protein and the three-function protein provided by the invention can synergistically regulate blood sugar and lipid levels in vivo, meet multiple requirements of patients with type 2 diabetes for reducing blood sugar, relieving liver fatty degeneration, reducing weight, improving circulating lipid metabolism disorder and the like, and are better in biological safety and tolerance and longer in in-vivo half-life period.

The invention discloses a rice grain type protein Os03g0762000 as well as a coding gene and application thereof. The rice grain type protein Os03g0762000 has an amino acid sequence as shown in SEQ ID NO.2, or is a functional equivalent variant formed by substitution, deletion or addition of one or more amino acid residues in the sequence as shown in SEQ ID NO.2; the coding gene has a nucleotide sequence as shown in SEQ ID NO.1, or a nucleotide sequence which is hybridized with SEQ ID NO.1 and codes the same functional protein. The invention discloses a method for cultivating a small-grain high-quality variety by using the gene, namely editing a specific position of the gene by a gene editing method so as to obtain a small-grain rice germplasm. The regulatory gene is good in regulation effect, compared with a wild type, the rice grain length and grain width are obviously reduced, and the characteristics of the regulatory gene show unique application value in rice mechanized hybrid breeding.

The invention belongs to the technical field of biology, and discloses a rice heat-resistant gene OsBGLU34, which is any one of the following nucleic acids a-c: a nucleic acid consisting of a nucleotide sequence as shown in SEQ ID NO.1, b nucleic acid consisting of a nucleotide sequence as shown in SEQ ID NO.2, c nucleic acid consisting of a nucleotide sequence as shown in SEQ ID NO.3; the b nucleic acid is composed of a nucleotide sequence, except for a, for coding the protein shown in SEQ ID NO.1; and c is a nucleic acid molecule which has no less than 90% of identity with the nucleotide sequences of a and b and expresses protein with the same function. The invention also discloses application of the OsBGLU34 gene in regulation and control of heat resistance and maturing rate of plants, especially regulation and control effect under temperature increase stress at night. Gene expression analysis finds that expression of the OsBGLU34 is up-regulated under high temperature stress at night, and overexpression of the OsBGLU34 can significantly reduce the maturing rate, indicating that the gene negatively regulates grain formation; a further functional verification experiment shows that overexpression of the OsBGLU34 can influence the adaptive capacity of the plant to a high-temperature environment, and the regulation and control effect of the OsBGLU34 is more remarkable especially under the temperature increasing condition at night.

A dual function protein is disclosed. The dual function protein may be prepared by linking a biologically active protein and an FGF mutant protein to an Fc region of an immunoglobulin. The dual function protein has improved pharmacological efficacy, in vivo duration and protein stability. The dual function protein exhibits improved pharmacological efficacy, in vivo duration and protein stability. A pharmaceutical composition containing the dual function protein as an active ingredient may be effectively used as a therapeutic agent for diabetes, obesity, dyslipidemia, metabolic syndrome, non-alcoholic fatty liver diseases, non-alcoholic steatohepatitis or cardiovascular diseases.

The invention relates to the field of bioinformatics, and provides a protein function prediction method and system based on deep learning. The method comprises the following steps: constructing a multi-modal data set of protein; performing feature extraction on the multi-modal data set through an encoder to obtain multi-modal features; training a neural network through the multi-modal features to obtain a prediction model; and predicting the function of the to-be-detected protein through the prediction model to obtain a prediction result. The protein function prediction accuracy is improved.

The invention discloses a prediction method, and particularly relates to a protein DNA binding tendency prediction method based on a multi-modal biomolecular model, which comprises the following steps: S1, inputting a protein sequence; s2, predicting a three-dimensional structure; s3, secondary structure calculation is carried out; s4, calculating the accessibility of the solvent; s5, performing protein function annotation; s6, generating feature representation; step S7, sample representation; s8, obtaining a training set; s9, generating all protein residue samples; step S10, constructing a protein map; step S11, building a graph neural network; step S12, adjusting through a convolutional layer; step S13, training and storing the model; and step S14, outputting a PWM matrix. The invention relates to a protein DNA binding tendency prediction method based on a multi-modal biomolecular model, which can reduce the calculation cost of the existing protein DNA binding tendency prediction method and improve the recognition accuracy.

The invention relates to the technical field of gene engineering, in particular to an atractylodes macrocephala terpene synthase gene AmTPS9 and a product coded by the same and application of the gene AmTPS9. The gene AmTPS9 has one of the following nucleotide sequences: (1) a nucleotide sequence as shown in SEQ ID NO.1; and (2) a nucleotide sequence which is obtained by substituting, deleting or adding one or more nucleotides to the nucleotide sequence as shown in SEQ ID NO.1 and expresses protein with the same function. According to the invention, a coding gene of an atractylodes macrocephala terpene synthase gene (AmTPS) is cloned from the rhizome of the atractylodes macrocephala, and the synthase can be applied to a pathway prepared by taking farnesyl pyrophosphate (FPP) as a substrate. By utilizing the gene provided by the invention, the content of terpenoids in bighead atractylodes rhizome can be increased through a genetic engineering technology.

The invention discloses application of Bombyx mori neuropeptide BommoOKAtype4 in preparation of a medicine for inhibiting melanoma cell growth, and belongs to the technical field of medical biology. Aiming at the technical problems that melanoma is high in malignancy degree, easy to transfer and limited in treatment means, and whether the bombyx mori neuropeptide BommoOKAtype4 can directly inhibit the growth of melanoma cells is not clear yet when the bombyx mori neuropeptide BommoOKAtype4 is mainly used for skin whitening before, the invention provides the application of the bombyx mori neuropeptide in preparing the medicine for inhibiting the melanoma cells. According to the silkworm neuropeptide, gene expression and protein functions of melanin synthesis key enzymes TYR, TRP1 and TRP2 are comprehensively inhibited by down-regulating expression of a core transcription factor MITF, so that melanoma cell proliferation is directly inhibited while melanin synthesis is inhibited, and therefore, the silkworm neuropeptide can be used for preparing drugs for treating melanoma and has a wide application prospect. A novel peptide candidate substance is provided for treatment of melanoma.

The invention discloses a strain of Bacteroides ovatus L2 and application of the strain of Bacteroides ovatus L2 in a product for preventing and treating vomitoxin toxicity. The strain is preserved in Guangdong Microbiological Culture Collection Center, the preservation number is GDMCC.No: 67205, and the preservation date is November 4, 2025. The strain is separated and purified from a healthy adult excrement sample, has the characteristics of good acid resistance, cholate resistance, gastrointestinal fluid resistance and the like, and is free of hemolysis and good in safety. The strain can effectively relieve the toxic effect induced by vomitoxin, mainly inhibits inflammatory factors and promotes expression of intestinal barrier functional proteins, can be applied to products of microecologics for preventing and treating DON toxicity, and has a good application prospect.

The present invention relates to a protein-ribonucleic acid complex comprising (I) at least one multi-functional protein or a set of at least two proteins and (II) a nucleic acid editor complex, a polynucleotide encoding the multi-functional protein (I) and its uses in the delivery of nucleic acids and gene editing tools. The present invention also relates to a nucleic acid delivery system, a plurality of polynucleotides, pharmaceutical compositions, a cell or a cell line, and kits. The present invention further relates to medical uses of the nucleic acid delivery system or the cell or cell line. Also provided are uses of a cell or a cell line in therapeutic and diagnostic applications, as well as in tissue engineering. Finally, the present invention further relates to an in vitro or in vivo method of editing a nucleic acid molecule in a target cell, and a method for nucleic acid delivery.

The invention discloses application of a methyltransferase gene EFS in regulation and control of plant salt stress resistance, and belongs to the technical field of plant molecular biology. The methyltransferase gene EFS is separated from arabidopsis thaliana, the full-length CDS of the methyltransferase gene EFS is 5418bp, the methyltransferase gene EFS has three conservative protein function structural domains which are respectively an SET structural domain, an AWS structural domain and a ZnfCW structural domain, and the protein coded by the methyltransferase gene EFS contains 1805 amino acids. After the methyltransferase gene EFS is knocked out, 100mM NaCl and 125mM NaCl are used for treating a mutant, so that the sensitivity of the mutant to the salt stress is increased, which indicates that the mutant plays an important role in the response of the plant to the salt stress, and therefore, the gene can be applied to the salt stress resistance of the plant.

The invention provides paeonia suffruticosa-derived phosphatidyldiacylglycerol acyltransferase 1-2 or a coding gene and application thereof, and belongs to the technical field of functional proteins. The invention relates to phosphatidyldiacylglycerol acyltransferase 1-2 from paeonia ostii, which comprises phosphatidyldiacylglycerol acyltransferase 1-2 from paeonia ostii and / or phosphatidyldiacylglycerol acyltransferase 1-2 from paeonia suffruticosa. Experiments show that the Paeonia ostii-sourced phosphatidyldiacylglycerol acyltransferase 1-2 and / or Paeonia fulva-sourced phosphatidyldiacylglycerol acyltransferase 1-2 not only can synthesize linoleic acid and alpha-linolenic acid by using exogenous polyunsaturated fatty acid, but also does not affect accumulation of yeast total lipid. The peony-sourced phosphatidyldiacylglycerol acyltransferase 1-2 provided by the invention provides a new method for biosynthesis of triacylglycerol, and provides a new way for genetic breeding of oil crops.